Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Eukaryotic translation initiation factor 4A (eIF4A) is a highly conserved, essential protein involved in the initiation phase of eukaryotic mRNA translation. It functions as an ATP-dependent RNA helicase and is a core component of the eIF4F complex, which mediates the recruitment of ribosomes to mRNA by unwinding secondary structures in the 5' untranslated region (UTR) of mRNAs. It has three isoforms: EIF4A1, EIF4A2, and EIF4A3. EIF4A1 and EIF4A2 are functionally interchangeable and essential for cap-dependent translation. EIF4A3 does not substitute for the other isoforms, and may inhibit translation under certain conditions. Its dysregulation has been linked to cancer progression.
ATP-dependent RNA helicase activity; unwinds mRNA secondary structures to facilitate ribosome scanning.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic Translation Initiation Factor 4A (eIF4A).